OxyChip Implantation and Subsequent Electron Paramagnetic Resonance Oximetry in Human Tumors Is Safe and Feasible: First Experience in 24 Patients.

导出 LinkOut

翻译打印收藏纠错

作者： Philip E,Schaner ^[1] ; Jason R,Pettus ^[2] ; Ann Barry,Flood ^[3] ; Benjamin B,Williams ^[1] ; Lesley A,Jarvis ^[2] ; Eunice Y,Chen ^[3] ; David A,Pastel ^[4] ; Rebecca A,Zuurbier ^[2] ; Roberta M,diFlorio-Alexander ^[3] ; Harold M,Swartz ^[5] ; Periannan,Kuppusamy ^[1]

作者单位： Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. ^[1] Geisel School of Medicine, Dartmouth College, Hanover, NH, United States. ^[2] Norris Cotton Cancer Center, Lebanon, NH, United States. ^[3] Department of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. ^[4] Department of Radiology, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. ^[5] Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. ^[6]

关键词 OxyChip clinical trial electron paramagnetic resonance feasibility hypoxia oximetry safety

DOI 10.3389/fonc.2020.572060

PMID 33194670

发布时间 2021-07-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2020年10卷

572060页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

OxyChip Implantation and Subsequent Electron Paramagnetic Resonance Oximetry in Human Tumors Is Safe and Feasible: First Experience in 24 Patients.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

OxyChip Implantation and Subsequent Electron Paramagnetic Resonance Oximetry in Human Tumors Is Safe and Feasible: First Experience in 24 Patients.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除